Literature DB >> 3846586

Multiple-dose vials: persistence of bacterial contaminants and infection control implications.

R N Longfield, L P Smith, J N Longfield, J Coberly, D Cruess.   

Abstract

Due to sporadic infections attributed to contaminated multiple-dose medication vials (MDV), some authorities have suggested discarding all MDV within 24 hours. We inoculated 11 commonly used medications with suspensions of 10 bacterial species previously associated with contaminated parenteral solutions and determined microbial persistence at both room and refrigerator temperature. At 22 degrees C, atropine, curare, folic acid, NPH insulin and triamcinolone did not allow microbial persistence beyond 4 hours. Lidocaine and heparin were sterile by 24 hours. Regular insulin, immune serum globulin, and myochrysine allowed persistence for up to 7 days. At 4 degrees C, bacterial persistence was significantly prolonged for all medications including those MDV requiring refrigeration. No organisms proliferated; however, F. meningosepticum and P. maltophilia were particularly persistent at both temperatures. The risk of persistent MDV contamination appears to be dependent upon specific pharmaceutical, microbe and storage temperature interactions. Recommendations for the refrigeration of MDV medications may require reevaluation on a product-by-product basis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3846586     DOI: 10.1017/s0195941700061415

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  2 in total

1.  Control of microbial contamination in unpreserved eyedrops.

Authors:  G B Oldham; V Andrews
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

2.  Bacterial contamination of single- and multiple-dose vials after multiple use and intravenous admixtures in three different hospitals in iran.

Authors:  Hossein Khalili; Mehdi Sheikhbabayi; Nasser Samadi; Hossein Jamalifar; Dina Dalili; Nasrin Samadi
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.